Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

152 results
Display

Prediction of 12-Week Remission by Psychopharmacological Treatment Step in Patients With Depressive Disorders

Jin YT, Kim HY, Jhon M, Kim JW, Kang HJ, Lee JY, Kim SW, Shin IS, Kim JM

Objective To investigate the predictors of remission by 4 treatment steps in depressive outpatients receiving 12-week psychopharmacotherapy. Methods Patients were consecutively recruited at a university hospital in South Korea from March...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Adherence to Antipsychotic Drugs by Medication Possession Ratio for Schizophrenia and Similar Psychotic Disorders in the Republic of Korea: A Retrospective Cohort Study

Cho SJ, Kim J, Lee JY, Sohn JH

Objective: Pharmacotherapy is considered as an essential element in the treatment of psychotic disorders including schizophrenia. Discontinuation of antipsychotic drugs increases medical use and economic burden. Therefore, maintenance of medication...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Bipolar Disorder 2022: Children and Adolescents

Yang CM, Bahk WM, Woo YS, Jeong JH, Seo JS, Choo IH, Kim W, Lee JG, Jung MH, Jon DI, Park SY, Sohn I, Kim MD, Yoon BH, Shim SH

Objectives The objective of this study was to revise the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) 2022: children and adolescents. Methods We performed a survey, using a questionnaire comprising...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacotherapy in obesity: the current state and the near future

Cho YJ, Kim KK

Background: In Korea, the prevalence of obesity, morbid obesity with serious complications, and childhood obesity are rapidly increasing. To control the obesity pandemic, both prevention and treatment are essential strategic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Current status of obesity treatment in Korea:based on the 2020 Korean Society for the Study of Obesity guidelines for obesity management

Rhee EJ

Background: Obesity is a complex disease, and its prevalence is gradually increasing globally. The increasing prevalence of obesity is shown to significantly affect the development of obesity-related comorbidities. This paper...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Bipolar Disorder 2022: Mixed Features

Kim W, Bahk WM, Woo YS, Jeong JH, Seo JS, Choo IH, Yang CM, Lee JG, Shim SH, Yoon BH, Park SY, Sohn I, Kim MD, Jung MH, Jon DI

Objectives Treatment guidelines or an algorithm can help clinicians implement better practices and clinical decisions. Therefore, the Korean Medication Algorithm Project for Bipolar Disorder 2022 (KMAP-BP 2022) was revised again...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Bipolar Disorder 2022: Depressive Episode

Seo JS, Woo YS, Bahk WM, Jeong JH, Yoon BH, Choo IH, Yang CM, Kim W, Lee JG, Shim SH, Jung MH, Jon DI, Park SY, Sohn I, Kim MD

Objectives After the Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) was developed in 2002, its fifth revision was completed in 2022 to reflect the recent rapid developments and research...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Bipolar Disorder 2022: Manic Episode

Woo YS, Bahk WM, Jeong JH, Yoon BH, Seo JS, Choo IH, Yang CM, Kim W, Lee JG, Shim SH, Jung MH, Jon DI, Park SY, Sohn I, Kim MD

Objectives The Korean Medication Algorithm Project for Bipolar Disorder (KMAP-BP) is a consensus-based medication guideline. To reflect advances in pharmacotherapy for bipolar disorders, we updated KMAP-BP to provide more timely...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Bipolar Disorder 2022: Overview

Kim W, Bahk WM, Woo YS, Jeong JH, Seo JS, Choo IH, Yang CM, Lee JG, Shim SH, Jung MH, Jon DI, Park SY, Sohn I, Kim MD, Yoon BH

Objectives The pharmacotherapy of bipolar disorder is complex. A treatment guideline or algorithm can help clinicians implement better practices and clinical decisions. Therefore, the Korean Medication Algorithm Project for Bipolar...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The Korean Medication Algorithm Project for Depressive Disorder 2021: Comparisons with Other Treatment Guidelines

Woo YS, Bahk WM, Seo JS, Park YM, Kim W, Jeong JH, Shim SH, Lee JG, Jang SH, Yang CM, Wang SM, Jung MH, Sung HM, Choo IH, Yoon BH, Lee SY, Jon DI, Min KJ

The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) first was published in 2002, and has been revised four times, in 2006, 2012, 2017, and 2021. In this review, we...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
2021 Clinical Practice Guidelines for Diabetes: Pharmacotherapy and the Korean Diabetes Association Support System

Hur KY

The most important change introduced in the pharmacotherapy session for the 2021 Clinical Practice Guidelines for Diabetes is the recommendation of two different strategies according to the patient’s condition. One...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmacotherapy for Patients Complaining With Somatic Symptoms

Lee KK

Patients complaining with somatic symptoms are very common in clinical practice, and are often consulted to medical department. But it is difficult to treat well. The treatment of somatic symptom...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A narrative review on adverse effects of dasatinib with a focus on pharmacotherapy of dasatinib-induced pulmonary toxicities

Nekoukar Z, Moghimi M, Salehifar E

Chronic myeloid leukemia (CML), a myeloproliferative disorder caused by the over activity of BCR-ABL1 (breakpoint cluster region-Abelson), has been successfully treated by Tyrosine kinase inhibitors (TKIs). While imatinib is known...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm for Depressive Disorder 2021, Fourth Revision: An Executive Summary

Seo JS, Bahk WM, Woo YS, Park YM, Kim W, Jeong JH, Shim SH, Lee JG, Jang SH, Yang CM, Wang SM, Jung MH, Sung HM, Choo IH, Yoon BH, Lee SY, Jon DI, Min KJ

Objective: In the 19 years since the Korean College of Neuropsychopharmacology and the Korean Society for Affective Disorders developed the Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) in 2002,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Combined Medication with Stimulants and Non-stimulants for Attention-deficit/hyperactivity Disorder

Bahn GH, Seo K

Objective: To study the efficiency and indication of combined medication with a stimulant and non-stimulant for attention-deficiency/hyperactivity disorder (ADHD), herein, the authors examined children and adult patients with ADHD. Methods: Subjects...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Survival, Prognosis, and Clinical Feature of Refractory Myasthenia Gravis: a 15-year Nationwide Cohort Study

Jeong S, Noh Y, Oh IS, Hong YH, Shin JY

Background: Myasthenia gravis (MG) is a rare classic autoimmune disease where immunosuppressant therapies have been successful to reduce MG attributable mortality fairly well. However, patients with refractory MG (rMG) among...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pathological Worry is Related to Poor Long-Term Pharmacological Treatment Response in Patients With Panic Disorder

Kim HJ, Kim JE, Lee SH

Objective Several predictors of unfavorable pharmacological treatment response (PTR) in panic disorder (PD) patients have been suggested, such as the duration of the illness, presence of agoraphobia, depression, being a...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Korean Medication Algorithm Project for Depressive Disorder 2021 (I): Treatment Strategies for Major Depressive Episode

Woo YS, Bahk WM, Seo JS, Park YM, Kim W, Jeong JH, Shim SH, Lee JG, Jang SH, Wang SM, Jung MH, Sung HM, Choo IH, Yoon BH, Lee SY, Jon DI, Min KJ

Objectives The Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) is a consensus-based medication guideline. To reflect advances in pharmacotherapy for depressive disorders, we have undertaken a fourth revision of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Predictors of Remission in Acute and Continuation Treatment of Depressive Disorders

Kim HY, Lee HJ, Jhon M, Kim JW, Kang HJ, Lee JY, Kim SW, Shin IS, Kim JM

Objective: To identify factors predicting remission of depression during acute (12 weeks) and continuation treatment (12 months) using a 1-year, naturalistic prospective study design. Methods: Patients with depressive disorders were recruited...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pharmachologic Prophylaxis for Post-Endoscopic Retrograde Cholangiopancreatography Pancreatitis

Choi JH, Lee SH

Post-endoscopic retrograde cholangiopancreatography pancreatitis (PEP) is one of the most burdensome adverse events, occurs in about 3 to 15 percent of patients after the procedure. Various and extensive attempts have...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2022 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr